STUART MISHELOF: Open Payments
NPI 1821300534 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,383 in 84 payments from 17 companies in 2025. Trend: 2023 $906 · 2024 $1,408 · 2025 $1,383
Food & beverage: $1,383
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $670 |
| Amgen Inc. | 7 | $152 |
| Dexcom, Inc. | 3 | $66 |
| Novo Nordisk Inc | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| PFIZER INC. | 3 | $55 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Phathom Pharmaceuticals, Inc. | 6 | $46 |
| Lilly USA, LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
Products named: QULIPTA, UBRELVY, EVENITY, VRAYLAR, Dexcom G6 Transmitter, INJECTAFER, VOQUEZNA, Rybelsus.
Industry payments across CA — which companies pay providers there.
